Search Results - Daniel E. Johnson

Refine Results
  1. 1
    The ubiquitin–proteasome system: opportunities for therapeutic intervention in solid tumors

    The ubiquitin–proteasome system: opportunities for therapeutic intervention in solid tumors by Daniel E. Johnson

    Published 2014
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Liberation of functional p53 by proteasome inhibition in human papilloma virus-positive head and neck squamous cell carcinoma cells promotes apoptosis and cell cycle arrest

    Liberation of functional p53 by proteasome inhibition in human papilloma virus-positive head and neck squamous cell carcinoma cells promotes apoptosis and cell cycle arrest by Changyou Li, Daniel E. Johnson

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Recent advances in the development of anticancer agents targeting cell death inhibitors in the Bcl-2 protein family

    Recent advances in the development of anticancer agents targeting cell death inhibitors in the Bcl-2 protein family by Sanjeev Shangary, Daniel E. Johnson

    Published 2003
    Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    Bortezomib induces autophagy in head and neck squamous cell carcinoma cells via JNK activation

    Bortezomib induces autophagy in head and neck squamous cell carcinoma cells via JNK activation by Changyou Li, Daniel E. Johnson

    Published 2011
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Triggering Pyroptosis in Cancer

    Triggering Pyroptosis in Cancer by Daniel E. Johnson, Zhibin Cui

    Published 2025
    Get full text
    Revisão
    Save to List
    Saved in:
  6. 6
    An ATRActive future for differentiation therapy in AML

    An ATRActive future for differentiation therapy in AML by Daniel E. Johnson, Robert L. Redner

    Published 2015
    Get full text
    Revisão
    Save to List
    Saved in:
  7. 7
    A Novel Promoter for Vascular Endothelial Growth Factor Receptor (flt-1) That Confers Endothelial-specific Gene Expression

    A Novel Promoter for Vascular Endothelial Growth Factor Receptor (flt-1) That Confers Endothelial-specific Gene Expression by Kaoru Morishita, Daniel E. Johnson, Lewis T. Williams

    Published 1995
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    New Therapies in Head and Neck Cancer

    New Therapies in Head and Neck Cancer by Rodell T. Santuray, Daniel E. Johnson, Jennifer R. Grandis

    Published 2018
    Get full text
    Revisão
    Save to List
    Saved in:
  9. 9
    Targeting the JAK/STAT pathway in solid tumors

    Targeting the JAK/STAT pathway in solid tumors by Zoya Qureshy, Daniel E. Johnson, Jennifer R. Grandis

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Sulforaphane Causes Autophagy to Inhibit Release of Cytochrome <i>c</i> and Apoptosis in Human Prostate Cancer Cells

    Sulforaphane Causes Autophagy to Inhibit Release of Cytochrome <i>c</i> and Apoptosis in Human Prostate Cancer Cells by Anna Herman-Antosiewicz, Daniel E. Johnson, Shivendra V. Singh

    Published 2006
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    EGFR-targeted therapies in the post-genomic era

    EGFR-targeted therapies in the post-genomic era by Mary Jue Xu, Daniel E. Johnson, Jennifer R. Grandis

    Published 2017
    Get full text
    Revisão
    Save to List
    Saved in:
  12. 12
    An update: emerging drugs to treat squamous cell carcinomas of the head and neck

    An update: emerging drugs to treat squamous cell carcinomas of the head and neck by Yoon Se Lee, Daniel E. Johnson, Jennifer R. Grandis

    Published 2018
    Get full text
    Revisão
    Save to List
    Saved in:
  13. 13
    Bortezomib induces apoptosis via Bim and Bik up-regulation and synergizes with cisplatin in the killing of head and neck squamous cell carcinoma cells

    Bortezomib induces apoptosis via Bim and Bik up-regulation and synergizes with cisplatin in the killing of head and neck squamous cell carcinoma cells by Changyou Li, Rongxiu Li, Jennifer R. Grandis, Daniel E. Johnson

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Isolation of an additional member of the fibroblast growth factor receptor family, FGFR-3.

    Isolation of an additional member of the fibroblast growth factor receptor family, FGFR-3. by Kathleen S. Keegan, Daniel E. Johnson, L T Williams, M J Hayman

    Published 1991
    Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Targeting the IL-6/JAK/STAT3 signalling axis in cancer

    Targeting the IL-6/JAK/STAT3 signalling axis in cancer by Daniel E. Johnson, Rachel A. O’Keefe, Jennifer R. Grandis

    Published 2018
    Get full text
    Revisão
    Save to List
    Saved in:
  16. 16
    The human fibroblast growth factor receptor genes: a common structural arrangement underlies the mechanisms for generating receptor forms that differ in their third immunoglobulin domain.

    The human fibroblast growth factor receptor genes: a common structural arrangement underlies the mechanisms for generating receptor forms that differ in their third immunoglobulin... by Daniel E. Johnson, Jian Lu, Hubert C. Chen, Sabine Werner, L T Williams

    Published 1991
    Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Targeting STAT3 in Cancer with Nucleotide Therapeutics

    Targeting STAT3 in Cancer with Nucleotide Therapeutics by Yue-Ting Kara Lau, Malini Ramaiyer, Daniel E. Johnson, Jennifer R. Grandis

    Published 2019
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  18. 18
    Caspase‐8 mutations in head and neck cancer confer resistance to death receptor‐mediated apoptosis and enhance migration, invasion, and tumor growth

    Caspase‐8 mutations in head and neck cancer confer resistance to death receptor‐mediated apoptosis and enhance migration, invasion, and tumor growth by Changyou Li, Ann Marie Egloff, Malabika Sen, Jennifer R. Grandis, Daniel E. Johnson

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Differential splicing in the extracellular region of fibroblast growth factor receptor 1 generates receptor variants with different ligand-binding specificities.

    Differential splicing in the extracellular region of fibroblast growth factor receptor 1 generates receptor variants with different ligand-binding specificities. by Sabine Werner, D S Duan, C de Vries, K G Peters, Daniel E. Johnson, L T Williams

    Published 1992
    Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    DNMT3A and IDH mutations in acute myeloid leukemia and other myeloid malignancies: associations with prognosis and potential treatment strategies

    DNMT3A and IDH mutations in acute myeloid leukemia and other myeloid malignancies: associations with prognosis and potential treatment strategies by Annie Im, Alison R. Sehgal, Martin Carroll, B. Douglas Smith, Ayalew Tefferi, Daniel E. Johnson, Michael Boyiadzis

    Published 2014
    Get full text
    Revisão
    Save to List
    Saved in:

Search Tools: